IMMUNOSUPPRESSION SWITCH IN PEDIATRIC HEART-TRANSPLANT RECIPIENTS - CYCLOSPORINE TO FK-506

被引:0
|
作者
SWENSON, JM
FRICKER, FJ
ARMITAGE, JM
CIPRIANI, LA
WEBBER, SA
MILLER, SA
LAWRENCE, KS
STARZL, TE
机构
[1] UNIV PITTSBURGH,PITTSBURGH,PA 15260
[2] CHILDRENS HOSP,PITTSBURGH,PA 15213
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
  • [1] IMMUNOSUPPRESSION SWITCH IN PEDIATRIC HEART-TRANSPLANT RECIPIENTS - CYCLOSPORINE TO FK-506
    SWENSON, JM
    FRICKER, FJ
    ARMITAGE, JM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (05) : 1183 - 1188
  • [2] NEPHROTOXICITY OF FK-506 AND CYCLOSPORINE WHEN USED AS PRIMARY IMMUNOSUPPRESSION IN LIVER-TRANSPLANT RECIPIENTS
    PORAYKO, MK
    TEXTOR, SC
    KROM, RAF
    HAY, JE
    GORES, GJ
    WAHLSTROM, HE
    SANCHEZURDAZPAL, L
    RICHARDS, T
    CROTTY, P
    BEAVER, S
    WIESNER, RH
    [J]. TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 665 - 668
  • [3] COMPARATIVE-STUDY OF FK-506, CYCLOSPORINE, AND TRIPLE REGIMEN IMMUNOSUPPRESSION WITH FK-506, CYCLOSPORINE, AND MIZORIBINE
    SATO, K
    YOKOTA, K
    MATSUI, T
    IMAI, K
    TAKISHIMA, T
    NAKAYAMA, Y
    OSAKABE, T
    YOSHIDA, M
    MIENO, H
    OMIYA, H
    HIKI, Y
    KAKITA, A
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3296 - 3299
  • [4] METABOLIC EFFECTS OF CYCLOSPORINE-A AND FK-506 IN LIVER-TRANSPLANT RECIPIENTS
    KRENTZ, AJ
    DOUSSET, B
    MAYER, D
    MCMASTER, P
    BUCKELS, J
    CRAMB, R
    SMITH, JM
    NATTRASS, M
    [J]. DIABETES, 1993, 42 (12) : 1753 - 1759
  • [5] FK-506 (FK) IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION
    ELLIS, D
    WEICHLER, N
    GILBOA, N
    SHAPIRO, R
    TZAKIS, A
    [J]. PEDIATRIC RESEARCH, 1991, 29 (04) : A341 - A341
  • [6] THE SPECTRUM OF ASPERGILLOSIS IN LIVER-TRANSPLANT PATIENTS - COMPARISON OF FK-506 AND CYCLOSPORINE IMMUNOSUPPRESSION
    TORRECISNEROS, J
    MANEZ, R
    KUSNE, S
    ALESSIANI, M
    MARTIN, M
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3040 - 3041
  • [7] THERAPY WITH FK-506 IN PEDIATRIC LIVER RECIPIENTS
    ROSH, JR
    SCHWERSENZ, AH
    SCHWARTZ, M
    MORAN, V
    LELEIKO, N
    LELEIKO, VMN
    MILLER, CM
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (01) : 152 - 153
  • [8] COMPARISON OF RISK-FACTORS IN FK-506 AND CYCLOSPORINE-A TREATED TRANSPLANT RECIPIENTS
    HOHAGE, H
    BRUCKNER, D
    ARLT, M
    BUCHHOLZ, B
    SPIEKER, C
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1091 - 1091
  • [9] CYCLOSPORINE VS FK-506 IMMUNE SUPPRESSION IN PEDIATRIC HEART-TRANSPLANTATION
    FRICKER, FJ
    ARMITAGE, JM
    PAHL, E
    MICHAELS, M
    ROBICHAUX, W
    LAWRENCE, K
    HANGARD, L
    CIPRIANI, L
    BEERMAN, LB
    NECHES, WH
    ETTEDGUI, JA
    FISCHER, DR
    PARK, SC
    SHERMAN, FS
    ZUBERBUHLER, JR
    STARZL, TE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04): : 424 - 424
  • [10] FK-506 VERSUS CYCLOSPORINE
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 511 - 512